MedicarePartD.guide

A non-government resource built from CMS public data

BUPRENORPHINE 7.5 ug/h Patch, Extended Release

Coverage in Nevada (CMS PDP Region 29).

4 of 10 stand-alone Part D plans in Nevada cover this drug on tier 3–4.

4 of 4 plans apply a prior authorization, step therapy or quantity limit.

75 Medicare Advantage plans in NV do cover it

Medicare Advantage plans carry their own formularies, separate from stand-alone Part D. A patient on an MA-PD plan may have coverage even where no PDP lists the drug. NV: 75 plans.

Every plan that covers it

PlanTier30-day preferred90-day mailUnit costEst. 30-day fillRestrictions
AARP Medicare Rx Preferred from UHC (PDP)$139.10/mo premium · $130.00 deductible3Preferred Brand18%18%$44.7127$178.854 units
  • Quantity limit 4 per 28 days
Humana Basic Rx Plan (PDP)$0.00/mo premium · $615.00 deductible4Non-Preferred Drug32%—$64.3827$257.534 units
  • Prior authorization
  • Quantity limit 4 per 28 days
Humana Value Rx Plan (PDP)$43.70/mo premium · $601.00 deductible4Non-Preferred Drug34%—$64.8847$259.544 units
  • Prior authorization
  • Quantity limit 4 per 28 days
Humana Premier Rx Plan (PDP)$148.70/mo premium · $0.00 deductible4Non-Preferred Drug50%50%$64.1003$256.404 units
  • Prior authorization
  • Quantity limit 4 per 28 days

Cost-sharing is the initial coverage phase at a preferred pharmacy; a percentage is coinsurance of the plan’s negotiated price, and the deductible may apply first. CMS publishes a negotiated price per unit, so the 30-day fill is shown only where the plan’s own quantity limit supplies the quantity.

See coverage in all 39 regions →